Loomis, Sayles & Company’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.9M Buy
980,439
+140,377
+17% +$5.54M 0.05% 137
2025
Q4
$38.3M Buy
840,062
+217,860
+35% +$9.7M 0.05% 142
2025
Q3
$26.3M Buy
+622,202
New +$23.4M 0.03% 195
2020
Q3
Sell
-1,122,401
Closed -$21.5M 655
2020
Q2
$21.5M Buy
1,122,401
+97,510
+10% +$2.07M 0.03% 208
2020
Q1
$17.3M Buy
1,024,891
+299,053
+41% +$7.67M 0.04% 191
2019
Q4
$19.7M Sell
725,838
-1,779
-0.2% -$43.7K 0.03% 219
2019
Q3
$19.8M Buy
+727,617
New +$20.6M 0.04% 214

Other funds holding AORT

Loomis, Sayles & Company's AORT Position: Q1 2026 in Review

Loomis, Sayles & Company increased its Artivion (AORT) stake by 17% in Q1 2026, buying an estimated $5.54M and bringing the position to 980,439 shares worth $35.9M. The position accounts for 0.05% of the portfolio, ranked #137.

Loomis, Sayles & Company first reported a position in AORT in Q3 2019 and has held it in 7 quarters since. The position peaked at $38.3M in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Loomis, Sayles & Company held 980,439 shares of Artivion worth $35.9M as of Q1 2026.
  • Loomis, Sayles & Company bought 140,377 Artivion shares in Q1 2026, an estimated $5.54M.
  • Artivion made up 0.05% of Loomis, Sayles & Company's portfolio in Q1 2026, its #137 holding.
  • Loomis, Sayles & Company first reported a position in Artivion in Q3 2019 and has held it in 7 quarters since.
  • Loomis, Sayles & Company's Artivion position peaked at $38.3M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.